Endo Health (ENDP) Approves $450M Common Buyback
Tweet
Share
E-mailGet Alerts ENDP Hot Sheet
Join SI Premium – FREE
Endo Health Solutions (Nasdaq: ENDP), announced today that its Board of Directors has authorized the company to repurchase up to $450 million of its common stock through March 2015.
The specific timing and number of shares repurchased will be determined by Endo management, at its discretion, and will vary based on market conditions, securities law limitations and other factors. The repurchases will be made using cash resources, and the program may be suspended or discontinued at any time with prior notice. The stock purchases may be made, from time to time, through a variety of methods including open market purchases, pre-set purchase programs, privately negotiated transactions and accelerated stock buyback agreements.
The specific timing and number of shares repurchased will be determined by Endo management, at its discretion, and will vary based on market conditions, securities law limitations and other factors. The repurchases will be made using cash resources, and the program may be suspended or discontinued at any time with prior notice. The stock purchases may be made, from time to time, through a variety of methods including open market purchases, pre-set purchase programs, privately negotiated transactions and accelerated stock buyback agreements.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Swiss Water gets TSX nod to buy back up to 650,000 shares
- Ericsson repurchases 2.5 million shares in weekly buyback
- Abacus Global Management approves $100M share buyback program
Create E-mail Alert Related Categories
Stock BuybacksRelated Entities
Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
